Fospropofol disodium is a short-acting, intravenous sedative-hypnotic agent belonging to the phenol derivative class, used for monitored anesthesia care in adult patients undergoing diagnostic or therapeutic… Read more
Fospropofol disodium is a short-acting, intravenous sedative-hypnotic agent belonging to the phenol derivative class, used for monitored anesthesia care in adult patients undergoing diagnostic or therapeutic procedures. By enhancing GABAergic neurotransmission, this compound facilitates rapid and reversible sedation. To ensure the integrity of analytical testing, pharmaceutical laboratories require high-quality reference standards that correspond to the parent drug. This category provides essential materials for rigorous quality control and impurity profiling, including specific related impurities and stable isotope labelled compounds like Fospropofol-d17 disodium salt. These labelled standards act as internal standards in mass spectrometry-based assays, allowing for precise quantification and method validation. Utilizing these comprehensive reference materials enables researchers and analysts to effectively identify, monitor, and control potential degradation products and process-related impurities throughout drug development and manufacturing processes.